As of 2025-07-16, the Relative Valuation of Emmaus Life Sciences Inc (EMMA) is (0.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.01 USD, the upside of Emmaus Life Sciences Inc based on Relative Valuation is -4078.5%.
The range of the Relative Valuation is (0.47) - (0.63) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.8x - 10.3x | 8.6x |
| Forward P/E multiples | 6.0x - 9.1x | 7.6x |
| Fair Price | (0.47) - (0.63) | (0.56) |
| Upside | -3480.5% - -4577.6% | -4078.5% |
| Date | P/E |
| 2025-07-15 | -0.20 |
| 2025-07-14 | -0.20 |
| 2025-07-09 | -0.20 |
| 2025-07-08 | -0.19 |
| 2025-07-07 | -0.20 |
| 2025-07-03 | -0.20 |
| 2025-07-01 | -0.20 |
| 2025-06-30 | -0.19 |
| 2025-06-27 | -0.22 |
| 2025-06-26 | -0.22 |
| 2025-06-20 | -0.22 |
| 2025-06-18 | -0.24 |
| 2025-06-13 | -0.24 |
| 2025-06-11 | -0.24 |
| 2025-06-09 | -0.24 |
| 2025-06-06 | -0.24 |
| 2025-06-02 | -0.23 |
| 2025-05-30 | -0.29 |
| 2025-05-27 | -0.19 |
| 2025-05-22 | -0.19 |
| 2025-05-16 | -0.20 |
| 2025-05-09 | -0.17 |
| 2025-05-06 | -0.19 |
| 2025-04-28 | -0.24 |
| 2025-04-23 | -0.24 |
| 2025-04-22 | -0.22 |